1. Coordinate Hsr Clearance with Industry Approvals
HSR notification under 15 U.S.C. §18a may be only one part of a regulated deal. Banks, insurers, and healthcare businesses can face separate rules. Map each track before setting the closing date.
| Review | Focus | Deal Question |
|---|---|---|
| HSR | Federal premerger filing | Must the parties file before closing? |
| Financial | Control and ownership | Is separate approval required? |
| Antitrust | Market effects | Could the deal reduce competition? |
| CFIUS | National security | Does foreign investment raise review issues? |
Sequence Financial Services Reviews
A bank or insurer deal can require state approval apart from HSR review. Banking Law §143-b requires prior approval for covered control deals and can presume control at 10% or more of voting stock. Insurance Law §1506 and 11 NYCRR 80-1 govern certain insurer control deals.
- Identify control approvals before signing.
- Keep ownership terms consistent.
- Place each approval on the closing calendar.
An HSR Filing review can establish the federal track while attorneys identify separate sector approvals.
Test Competition Risk Separately
Crossing an HSR threshold does not mean a deal violates antitrust law. Clayton Act §7 separately addresses deals that may substantially lessen competition or tend to create a monopoly.
- Identify overlapping products and services.
- Review buyer options and entry conditions.
- Examine deal documents discussing competitors.
2. Screen Private Equity Rollups before Each Acquisition
Serial acquisitions require more than checking the latest price. HSR aggregation can require some prior holdings to be considered with a new deal. The structure and seller matter.
Apply Aggregation Rules to the Deal at Hand
16 C.F.R. §§801.13-801.15 address aggregation of securities, assets, and entity interests. A later portfolio deal does not automatically make an earlier deal reportable.
- Identify the parent entities.
- Classify the assets, securities, or interests.
- Check relevant prior acquisitions.
- Apply exemptions before calculating value.
For asset-heavy deals, an Asset Acquisitions review can connect structure with HSR analysis.
Use the Threshold in Effect at Closing
For closings on or after February 17, 2026, the minimum size-of-transaction threshold is $133.9 million. Other tests and exemptions still matter.
- Use the threshold effective at closing.
- Recalculate value after deal changes.
- Recheck reportability when another tranche is added.
3. Analyze Local Competition in Consumer Deals
Retail, grocery, pharmacy, and hospitality deals may require geographic analysis. HSR reportability and merger review answer different questions, so filing status alone does not resolve competitive risk.
Map Store and Customer Overlap
The analysis should reflect how customers choose among real alternatives. Dense commercial areas may differ from a national market view.
- Map overlapping stores and services.
- Review pricing and strategy documents.
- Identify areas with fewer alternatives.
An Antitrust and Competition Law review can separate market concerns from the HSR filing question.
Assess Remedies after the Risk Is Defined
If an agency identifies a market concern, the parties may consider a remedy. The evidence should drive that analysis rather than an assumption that assets must be sold.
- Identify operations tied to the concern.
- Preserve evidence about buyer options.
- Test whether a proposed remedy is workable.
4. Classify Real Estate and Hospitality Assets before Filing
Portfolio deals can mix real property with operating firms. Some acquisitions may qualify under 16 C.F.R. §802.2, but the assets must be classified first.
Separate Exempt Property from Other Assets
Real estate in the package does not make the full deal exempt. The result depends on the property, its use, the structure, and the applicable rule.
- Identify each asset category.
- Test the applicable §802.2 exemption.
- Value non-exempt assets under HSR rules.
5. Run Cross-Border and Cfius Reviews Separately
A foreign acquirer may face HSR requirements. The deal may also trigger foreign merger-control or national-security review under separate tests.
Coordinate Filing and Closing Calendars
Map parallel reviews before signing. Filing narratives need not match word for word, but unexplained fact gaps can complicate review.
- Identify relevant jurisdictions early.
- Compare filing and waiting periods.
- Track approvals that affect closing.
Screen Cfius Issues Independently
Foreign investment involving key technology, systems, or personal data can raise security issues apart from antitrust review. HSR clearance does not resolve CFIUS.
- Review the investor and ownership structure.
- Identify key technology, systems, or data.
- Keep CFIUS analysis separate from HSR reportability.
CFIUS Compliance analysis can run beside the merger timetable without combining the two legal standards.
6. Plan Healthcare Deals Around Parallel Review
Healthcare deals can combine federal antitrust review with separate ownership rules. For Article 28 entities, PHL §2801-a can require approval for establishment or ownership changes.
Separate Competition Review from Facility Approval
Identify the authority behind each review instead of treating every approval as part of HSR clearance.
- Map overlapping services or facilities.
- Review pipeline products where relevant.
- Identify ownership approvals.
7. Frequently Asked Questions
Can a private equity sponsor need another HSR filing for a portfolio deal?
Yes. Reportability depends on the parties, value, existing holdings, aggregation rules, and exemptions. Earlier portfolio deals do not by themselves decide the next filing obligation.
Does an HSR filing satisfy a financial approval?
No. HSR is a federal premerger process. A banking or insurance deal may require separate approval under the law governing that institution.
Can a real estate portfolio acquisition qualify for an HSR exemption?
Potentially. Certain property acquisitions may qualify under 16 C.F.R. §802.2. Mixed deals with operating firms or other assets require separate classification and valuation.
Does HSR clearance eliminate the need for CFIUS review?
No. HSR and CFIUS address different concerns. A deal may require both reviews, and completion of one process does not replace the other.
8. Coordinate Regulatory Clearance before Closing
Complex transactions rarely move through one review calendar. SJKP’s attorneys can assess HSR reportability, aggregation, competition risk, sector approvals, and cross-border review as distinct workstreams. An HSR merger filing representation attorney in Manhattan can help identify filing duties before the closing plan hardens when needed.
26 Aug, 2026
